New Study Affirms Safety of ICS in Pediatric Asthma: No Heightened Risk of Pneumonia Hospitalization
8 Jan 2024 • A nation-wide study, based on a large real-world sample of pediatric asthma patients (aged 2–17 years), found no association between inhaled corticosteroids (ICS) use and the risk of hospitalization due to pneumonia in pediatric patients.
Incidence rates of hospitalization for pneumonia were 14.5 and 14.6 per 10,000 patient-years for ICS users and non-users, respectively.
These findings provide reassuring evidence for clinicians and parents, emphasizing the safety of ICS in managing asthma in children without elevating pneumonia hospitalization risk.
Source: BMJ | Read full story